CCRB Logo

Trial Detail

CUHK_CCT00126

2007-12-05

Retrospective

nil

Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong

Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong

nil

Prof Warwick D. Ngan Kee

Dept of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong

+852 26322735

warwick@cuhk.edu.hk

The Chinese University of Hong Kong

Prof Warwick D. Ngan Kee

Dept of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong

+852 26322735

warwick@cuhk.edu.hk

The Chinese University of Hong Kong

Dose-response analysis methodology for epidural analgesia in the first stage of labour using ropivacaine and bupivacaine

Dose-response analysis methodology for epidural analgesia in the first stage of labour using ropivacaine and bupivacaine

nil

hong kong

Yes

2006-08-01

labour

Drug

ropivacaine, bupivacaine

30min

Allocation to receive a single randomized dose of ropivacaine or bupivacaine epidurally for analgesia in the first stage of labour

Inclusion criteria: American Society of Anesthesiologists physical status 1 or 2, nulliparous, uncomplicated singleton pregnancy, gestation greater than or equal to 36weeks, cephalic presentation, established labour with cervical dilatation less than or equal to 5 cm, baseline visual analogue scale pain score greater than or equal to 50 mm (scale: 0-100mm), requesting epidural analgesia in the first stage of labour.

Exclusion criteria: Inability or unwillingness to give informed consent, parenteral opioid received within the preceding 2 h, any contraindication to epidural analgesia or allergy to local anaesthetics.

18

50

Female

Interventional

Randomized

Dose comparison

Double-blind

Parallel

2006-08-09

50

Complete

Visual analogue scale pain scores in the first 30 min after administration.

nil

No

2013-01-10

ChiCTR-TRC-09000707

2010-05-04

Type Document Published On  
No documents yet.
  • Page 1 of 1.